Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Ferroptosis and cancer prognosis

Ferroptosis and cancer prognosis is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 32k research works in it since 1970. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the mechanisms and implications of ferroptosis in cancer, exploring topics such as the role of lipid peroxidation, the involvement of GPX4, the impact on the tumor microenvironment, and the interplay with immune cells. It also covers the use of RNA-sequencing for gene expression analysis in the context of ferroptosis and cancer.

  • Ferroptosis
  • Cancer
  • Cell Death
  • Tumor Microenvironment
  • Lipid Peroxidation
  • GPX4
  • Immune Cells
  • Oxidative Stress
  • RNA-sequencing
  • Gene Expression
Research works
32k
fractional, since 1970
In the world top 10%
3.2k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+145%
the tick is no change
Largest producer
China
78% of the 10 largest, 2022-now
Ferroptosis and cancer prognosis

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Ferroptosis and cancer prognosis research?

By volume, China and the United States publish the most (14k and 2k works in 2022-now).

By volume, 2022-now

  1. 1 China 14k works
  2. 2 United States 2k works
  3. 3 Japan 381 works
  4. 4 South Korea 331 works
  5. 5 India 329 works
  6. 6 Germany 255 works
  7. 7 Italy 254 works
  8. 8 United Kingdom 206 works
  9. 9 Taiwan 195 works
  10. 10 Iran 186 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 77.5%United States: 10.9%Japan: 2.1%South Korea: 1.8%6 others listed: 7.7%78%largest
China14k · 77.5%United States2,004 · 10.9%Japan381 · 2.1%South Korea331 · 1.8%6 others listed1,424 · 7.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Ferroptosis and cancer prognosis research?

By volume in 2022-now, Sun Yat-sen University publishes the most Ferroptosis and cancer prognosis research, followed by Nanjing Medical University and Shanghai Jiao Tong University.

By volume, 2022-now

  1. 1 Sun Yat-sen UniversityChina 430 works
  2. 2 Nanjing Medical UniversityChina 337 works
  3. 3 Shanghai Jiao Tong UniversityChina 303 works
  4. 4 Central South UniversityChina 293 works
  5. 5 Harbin Medical UniversityChina 260 works
  6. 6 Zhejiang UniversityChina 245 works
  7. 7 Fudan UniversityChina 234 works
  8. 8 Wuhan UniversityChina 233 works
  9. 9 Zhengzhou UniversityChina 226 works
  10. 10 Fujian Medical UniversityChina 211 works

Who are the leading researchers in Ferroptosis and cancer prognosis?

The most-cited researchers publishing on Ferroptosis and cancer prognosis include Zhong Lin Wang, George Davey Smith and Stacey L. Gabriel.

  1. 1 Zhong Lin Wang United States 491k citations
  2. 2 George Davey Smith United Kingdom 435k citations
  3. 3 Stacey L. Gabriel United States 402k citations
  4. 4 Robert John Tibshirani United States 396k citations
  5. 5 Guido Kroemer France 386k citations
  6. 6 Bert Vogelstein United States 373k citations
  7. 7 Gad A. Getz United States 364k citations
  8. 8 Elaine R. Mardis United States 346k citations
  9. 9 Hermann Brenner Germany 343k citations
  10. 10 Jun Wang China 340k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Ferroptosis and cancer prognosis?

The most cited paper in Ferroptosis and cancer prognosis is "Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death" (Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al., 2012), with 19,018 citations. Next come "Inferring tumour purity and stromal and immune cell admixture from expression data" (10,966) and "Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease" (7,867).

Most cited papers
#PaperReleasedCitations
1 Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al. · Cell Open access May 2012 19,018
2 Inferring tumour purity and stromal and immune cell admixture from expression data Kosuke Yoshihara, Maria Shahmoradgoli, Emmanuel Martínez et al. · Nature Communications Open access 11 Oct 2013 10,966
3 Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease Brent R. Stockwell et al. · Cell Open access Oct 2017 7,867
4 Regulation of Ferroptotic Cancer Cell Death by GPX4 Wan Seok Yang, Rohitha Sriramaratnam, Matthew Welsch et al. · Cell Open access 2014 7,814
5 Ferroptosis: mechanisms, biology and role in disease Xuejun Jiang, Brent R. Stockwell, Marcus Conrad · Nature Reviews Molecular Cell Biology ReviewOpen access 25 Jan 2021 7,650
All 100 most cited papers, with filters and sorting

Where is Ferroptosis and cancer prognosis research done?

The largest centres of Ferroptosis and cancer prognosis research in 2022-now are Shanghai (China), Beijing (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Baise City, Xi’an and Nantong.

Largest cities, 2022-now

  1. 1 ShanghaiChina 1.1k works
  2. 2 BeijingChina 1.1k works
  3. 3 GuangzhouChina 1k works
  4. 4 NanjingChina 590 works
  5. 5 WuhanChina 557 works
  6. 6 HangzhouChina 523 works
  7. 7 ChangshaChina 478 works
  8. 8 JinanChina 399 works
  9. 9 ChengduChina 374 works
  10. 10 ChongqingChina 346 works

Where it is the local speciality

  1. Baise CityCN · 33.9 works24×
  2. Xi’anCN · 29.0 works18×
  3. NantongCN · 164.6 works18×
  4. LuzhouCN · 84.8 works17×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Ferroptosis and cancer prognosis than the world average.

See Ferroptosis and cancer prognosis on the map

Where is the best place to study Ferroptosis and cancer prognosis?

Among universities, judged by research, Sun Yat-sen University, Wuhan University and CHA University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 17.46%fractional works in this field (log) →share of work in the world top 10% →CHA UniversityWuhan UniversityCentral South Univer…Sun Yat-sen University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sun Yat-sen UniversityChina 62.311.0%12.2×430 +106.9%
2Wuhan UniversityChina 60.814.6%9.6×233 +127.9%
3CHA UniversitySouth Korea 60.528.0%14.0×19 +211.3%
4Central South UniversityChina 60.111.8%8.9×294 +133.2%
5Harvard UniversityUnited States 60.017.8%1.8×98 +21.8%
6Columbia UniversityUnited States 60.025.3%1.3×24 +59.7%
7Fudan UniversityChina 59.612.8%8.7×234 +119.5%
8Shanghai Jiao Tong UniversityChina 58.510.7%6.2×303 +149.0%
9Ghent UniversityBelgium 57.833.4%0.6×8 +109.9%
10Nanjing Medical UniversityChina 57.49.2%22.2×337 +175.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Ferroptosis and cancer prognosis, country by country

Is Ferroptosis and cancer prognosis research growing?

Output in 2022-2025 was 145% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Ferroptosis and cancer prognosis.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Ferroptosis and cancer prognosis as a percentage of every work published that year, 0.073% in 2024.

still counting0.050%0.10%Ferroptosis and cancer prognosis0.087% in 202519801990200020102020

Fractional works of Ferroptosis and cancer prognosis over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Ferroptosis and cancer prognosis9.7% in 202520102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Ferroptosis and cancer prognosis. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.